RxDoctor Payments Data

Ashley Goss

Family · Interlochen, MINPI 1306432059

Payments from drug & device makers

$2,626in general payments, 2019–2025

Across 147 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$992
  • GSK$597
  • Lilly USA, LLC$172
  • AstraZeneca$136
  • Novo Nordisk$123
  • Boehringer Ingelheim$119
  • plus $488 from 16 others

What the payments were for

  • Food & beverage$2,626100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,626 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$23,763
FarxigaDapagliflozin Propanediol11$17,027
JardianceEmpagliflozin12$16,967
OzempicSemaglutide15$15,927
EliquisApixaban14$8,099
VyvanseLisdexamfetamine Dimesylate20$7,797
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$5,781
Albuterol Sulfate HfaAlbuterol Sulfate48$1,822
Atorvastatin Calcium119$1,309
Omeprazole54$1,074
Lisinopril78$840
Tamsulosin Hcl36$836
Duloxetine Hcl30$793
Hydroxyzine Hcl23$613
Losartan Potassium50$559

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$597$29,54439 claims
AstraZenecaFarxiga$136$17,02711 claims
Boehringer IngelheimJardiance$119$16,96712 claims
Novo NordiskOzempic$123$15,92715 claims
PfizerEliquis$21$8,09914 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$40$7,79720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Interlochen

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →